Skip to content
Home/Companies/Pharma/IPS Specials

IPS Specials

Pharma·UK·Exited 2022·Held 12yr
Entry
2010
Hold
12yr
Exit
2022

Who owns IPS Specials?

IPS Specials was owned by Elysian Capital through Elysian Capital I (2008 vintage) from 2010 to 2022, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-27

Elysian Capital
Most recent investor
Elysian Capital
Elysian Capital I · 2008 · Buyout
2 ownership periods · full history below

Key facts

HQUK
SectorPharma
StatusActive

Ownership history

1 ownership period · 1 lender on file

Exited
Last exited in 2022 to .
1 holder · 1 lender · 2010 · present
Elysian Capital
Elysian CapitalExited 2022
2010 · 2022(12yr) · Elysian Capital I · 2008 · Buyout
MBO · to
MOIC
–
Beechbrook Capital
Beechbrook CapitalLender
2014 · present(12yr) · Mezzanine II · 2014 · Mezzanine

More from Elysian Capital I

Other portfolio companies in the same fund.

Kelling Group
Exited 2018
IndustrialsUK· 2014
to
Wellbeing Software
Exited 2020
HealthTechUK· 2014
to
Axis Well Technology
Axis Well Technology
Exited 2023
EnergyUK· 2013
to
BXTAccelyon
Exited 2026
HealthcareUK· 2013
to
Tekmar Energy
Tekmar Energy
Exited 2018
ClimateTechUK· 2011
Volvox Group
Exited 2015
MobilityUK· 2011
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track IPS Specials

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy IPS Specials?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on IPS Specials.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue